Understanding NCAA Passer Rating: What It Is, How It Works, and Why It Matters

Since there is no Clemson football this weekend, I thought we could take a deeper look at one of the advanced metrics that ...

Kaynes Technologies and a can of worms? Here is what a deep dive into its financials and filings reveal

The Beneish M-Score is an effective, quick-screening tool to detect frauds. Developed by Professor Messod Beneish, this ...
The IslandOpinion

Natural Disasters

One’s thoughts, deep concern and sorrow; the media and peoples’conversation has been the late November cyclone. To quote ...

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23) and overall survival (HR=0.61; p=0.52) 3/3 (100%) of TSC-101-treated patients who reached two-year follow-up ...

Earlier use of CARVYKTI® (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 Data suggest ...